Blood cancer infection trial tests shorter antibiotic course to reduce resistance

NCT ID NCT07372131

First seen Jan 31, 2026 · Last updated May 08, 2026 · Updated 16 times

Summary

This study looks at whether blood cancer patients with a serious bloodstream infection can safely stop antibiotics sooner if they are stable for 72 hours, instead of the usual 10-day course. About 172 participants will be randomly assigned to either a personalized or standard antibiotic duration. The goal is to see if shorter treatment reduces antibiotic use and gut bacteria changes without increasing risks like fever return or death.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAM NEGATIVE INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Microbiology and Virology - IRCCS Humanitas Research Hospital

    RECRUITING

    Rozzano, Milan, 20089, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.